These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 30891102

  • 41. A Comparative Study of Serum Exosome Isolation Using Differential Ultracentrifugation and Three Commercial Reagents.
    Helwa I, Cai J, Drewry MD, Zimmerman A, Dinkins MB, Khaled ML, Seremwe M, Dismuke WM, Bieberich E, Stamer WD, Hamrick MW, Liu Y.
    PLoS One; 2017; 12(1):e0170628. PubMed ID: 28114422
    [Abstract] [Full Text] [Related]

  • 42. Exosomal miR-126 as a circulating biomarker in non-small-cell lung cancer regulating cancer progression.
    Grimolizzi F, Monaco F, Leoni F, Bracci M, Staffolani S, Bersaglieri C, Gaetani S, Valentino M, Amati M, Rubini C, Saccucci F, Neuzil J, Tomasetti M, Santarelli L.
    Sci Rep; 2017 Nov 10; 7(1):15277. PubMed ID: 29127370
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Thermophoretic Detection of Exosomal microRNAs by Nanoflares.
    Zhao J, Liu C, Li Y, Ma Y, Deng J, Li L, Sun J.
    J Am Chem Soc; 2020 Mar 18; 142(11):4996-5001. PubMed ID: 32134270
    [Abstract] [Full Text] [Related]

  • 45. Decreased levels of serum exosomal miR-638 predict poor prognosis in hepatocellular carcinoma.
    Shi M, Jiang Y, Yang L, Yan S, Wang YG, Lu XJ.
    J Cell Biochem; 2018 Jun 18; 119(6):4711-4716. PubMed ID: 29278659
    [Abstract] [Full Text] [Related]

  • 46. Exosomal and Non-Exosomal Urinary miRNAs in Prostate Cancer Detection and Prognosis.
    Foj L, Ferrer F, Serra M, Arévalo A, Gavagnach M, Giménez N, Filella X.
    Prostate; 2017 May 18; 77(6):573-583. PubMed ID: 27990656
    [Abstract] [Full Text] [Related]

  • 47. Different signatures of miR-16, miR-30b and miR-93 in exosomes from breast cancer and DCIS patients.
    Ni Q, Stevic I, Pan C, Müller V, Oliveira-Ferrer L, Pantel K, Schwarzenbach H.
    Sci Rep; 2018 Aug 28; 8(1):12974. PubMed ID: 30154547
    [Abstract] [Full Text] [Related]

  • 48. Clinical Relevance of Circulating, Cell-Free and Exosomal microRNAs in Plasma and Serum of Breast Cancer Patients.
    Schwarzenbach H.
    Oncol Res Treat; 2017 Aug 28; 40(7-8):423-429. PubMed ID: 28683441
    [Abstract] [Full Text] [Related]

  • 49. Circulating exosomal miR-125a-3p as a novel biomarker for early-stage colon cancer.
    Wang J, Yan F, Zhao Q, Zhan F, Wang R, Wang L, Zhang Y, Huang X.
    Sci Rep; 2017 Jun 23; 7(1):4150. PubMed ID: 28646161
    [Abstract] [Full Text] [Related]

  • 50. Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma.
    Lan F, Qing Q, Pan Q, Hu M, Yu H, Yue X.
    Cell Oncol (Dordr); 2018 Feb 23; 41(1):25-33. PubMed ID: 29076027
    [Abstract] [Full Text] [Related]

  • 51. Biomolecular characterization of exosomes released from cancer stem cells: Possible implications for biomarker and treatment of cancer.
    Kumar D, Gupta D, Shankar S, Srivastava RK.
    Oncotarget; 2015 Feb 20; 6(5):3280-91. PubMed ID: 25682864
    [Abstract] [Full Text] [Related]

  • 52. Study of circulating microRNA-125b levels in serum exosomes in advanced melanoma.
    Alegre E, Sanmamed MF, Rodriguez C, Carranza O, Martín-Algarra S, González A.
    Arch Pathol Lab Med; 2014 Jun 20; 138(6):828-32. PubMed ID: 24878024
    [Abstract] [Full Text] [Related]

  • 53. Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.
    Sohn W, Kim J, Kang SH, Yang SR, Cho JY, Cho HC, Shim SG, Paik YH.
    Exp Mol Med; 2015 Sep 18; 47(9):e184. PubMed ID: 26380927
    [Abstract] [Full Text] [Related]

  • 54. Diagnostic value of microRNAs derived from exosomes in bronchoalveolar lavage fluid of early-stage lung adenocarcinoma: A pilot study.
    Kim JE, Eom JS, Kim WY, Jo EJ, Mok J, Lee K, Kim KU, Park HK, Lee MK, Kim MH.
    Thorac Cancer; 2018 Aug 18; 9(8):911-915. PubMed ID: 29806739
    [Abstract] [Full Text] [Related]

  • 55. Exosome-encapsulated microRNAs as circulating biomarkers for colorectal cancer.
    Yan S, Han B, Gao S, Wang X, Wang Z, Wang F, Zhang J, Xu D, Sun B.
    Oncotarget; 2017 Sep 01; 8(36):60149-60158. PubMed ID: 28947960
    [Abstract] [Full Text] [Related]

  • 56. Cardiac progenitor cell-derived exosomes prevent cardiomyocytes apoptosis through exosomal miR-21 by targeting PDCD4.
    Xiao J, Pan Y, Li XH, Yang XY, Feng YL, Tan HH, Jiang L, Feng J, Yu XY.
    Cell Death Dis; 2016 Jun 23; 7(6):e2277. PubMed ID: 27336721
    [Abstract] [Full Text] [Related]

  • 57. Resistance Training Diminishes the Expression of Exosome CD63 Protein without Modification of Plasma miR-146a-5p and cfDNA in the Elderly.
    Estébanez B, Visavadiya NP, de Paz JA, Whitehurst M, Cuevas MJ, González-Gallego J, Huang CJ.
    Nutrients; 2021 Feb 19; 13(2):. PubMed ID: 33669497
    [Abstract] [Full Text] [Related]

  • 58. Study of microRNAs-21/221 as potential breast cancer biomarkers in Egyptian women.
    Motawi TM, Sadik NA, Shaker OG, El Masry MR, Mohareb F.
    Gene; 2016 Sep 30; 590(2):210-9. PubMed ID: 26827795
    [Abstract] [Full Text] [Related]

  • 59. Blood Circulating Exosomes Contain Distinguishable Fractions of Free and Cell-Surface-Associated Vesicles.
    Tamkovich S, Tutanov O, Efimenko A, Grigor'eva A, Ryabchikova E, Kirushina N, Vlassov V, Tkachuk V, Laktionov P.
    Curr Mol Med; 2019 Sep 30; 19(4):273-285. PubMed ID: 30868953
    [Abstract] [Full Text] [Related]

  • 60. Investigating the Potential and Pitfalls of EV-Encapsulated MicroRNAs as Circulating Biomarkers of Breast Cancer.
    Moloney BM, Gilligan KE, Joyce DP, O'Neill CP, O'Brien KP, Khan S, Glynn CL, Waldron RM, Maguire CM, Holian E, Naughton E, Elhadi M, Grealish AB, Malone C, McDermott E, Dockery P, Ritter T, Prina-Mello A, Kerin MJ, Dwyer RM.
    Cells; 2020 Jan 07; 9(1):. PubMed ID: 31936142
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.